A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
Condition: Ebola Virus DiseaseIntervention: Biological: VSV-ZEBOVSponsors: University of Oxford; World Health Organization; Wellcome Trust; Institute of Tropical Medicine, University of Tuebingen; Albert Schweitzer Hospital; Philipps University Marburg Medical Center; Universitätsklinikum Hamburg-Eppendorf; University Hospital, GenevaNot yet recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2014 Category: Research Source Type: clinical trials
A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
Condition: Ebola Virus DiseaseIntervention: Biological: VSV-ZEBOVSponsors: University of Oxford; World Health Organization; Wellcome Trust; Institute of Tropical Medicine, University of Tuebingen; Albert Schweitzer Hospital; Philipps University Marburg Medical Center; Universitätsklinikum Hamburg-Eppendorf; University Hospital, GenevaActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2014 Category: Research Source Type: clinical trials
A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
Condition: Ebola Virus DiseaseIntervention: Biological: VSV-ZEBOVSponsors: University of Oxford; World Health Organization; Wellcome Trust; Institute of Tropical Medicine, University of Tuebingen; Albert Schweitzer Hospital; Philipps University Marburg Medical Center; Universitätsklinikum Hamburg-Eppendorf; University Hospital, GenevaNot yet recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2014 Category: Research Source Type: clinical trials
VSV-ZEBOV Geneva Vaccine Trial
Condition: Ebola VirusIntervention: Biological: VSV-ZEBOVSponsors: University Hospital, Geneva; World Health Organization; Wellcome Trust; Universitätsklinikum Hamburg-Eppendorf; Philipps University Marburg Medical Center; Albert Schweitzer Hospital; Institute of Tropical Medicine, University of Tuebingen; KEMRI-Wellcome Trust Collaborative Research ProgramEnrolling by invitation - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2014 Category: Research Source Type: clinical trials
VSV-ZEBOV Geneva Vaccine Trial
Condition: Ebola VirusIntervention: Biological: VSV-ZEBOVSponsors: University Hospital, Geneva; World Health Organization; Wellcome Trust; Universitätsklinikum Hamburg-Eppendorf; Philipps University Marburg Medical Center; Albert Schweitzer Hospital; Institute of Tropical Medicine, University of Tuebingen; KEMRI-Wellcome Trust Collaborative Research ProgramActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2014 Category: Research Source Type: clinical trials
VSV-ZEBOV Geneva Vaccine Trial
Condition: Ebola VirusIntervention: Biological: VSV-ZEBOVSponsors: University Hospital, Geneva; World Health Organization; Wellcome Trust; Universitätsklinikum Hamburg-Eppendorf; Philipps University Marburg Medical Center; Albert Schweitzer Hospital; Institute of Tropical Medicine, University of Tuebingen; KEMRI-Wellcome Trust Collaborative Research ProgramEnrolling by invitation - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2014 Category: Research Source Type: clinical trials
